论文部分内容阅读
目的:探讨聚桂醇泡沫硬化剂注射治疗口腔颌面部静脉畸形的临床疗效。方法:27例口腔颌面部静脉畸形病例,病变部位给予次数、剂量不等的聚桂醇泡沫硬化剂注射治疗,随访6个月~2年,观察其临床疗效。结果:27例中,治愈8例(29.63%),基本治愈13例(48.15%),好转6例(22.22%),无效病例为0例,总有效率为100%。结论:聚桂醇泡沫硬化剂注射治疗口腔颌面部静脉畸形具有良好的临床疗效及安全性。
Objective: To investigate the clinical effect of lauromacrogol sclerosing agent in the treatment of venous malformations in oral and maxillofacial region. Methods: Twenty-seven cases of oral and maxillofacial venous malformations, the number of lesions and the dose of lauryl alcohol sclerosing agent injection were followed up for 6 months to 2 years. The clinical effects were observed. Results: Among the 27 cases, 8 cases were cured (29.63%), 13 cases (48.15%) were cured, 6 cases (22.22%) were cured, 0 cases were invalid and the total effective rate was 100%. Conclusion: The injection of lauromacrogol foam sclerotherapy has good clinical efficacy and safety in the treatment of oral and maxillofacial venous malformations.